Low vitamin D levels are related to decreased response to osteoporosis medicine

June 6, 2011 in Health

Women with low bone density are seven times more likely to benefit from a bisphosphonate drug when their vitamin D blood levels are above recent recommendations from the Institute of Medicine (IOM) as adequate for bone health. These new study results will be presented Saturday at The Endocrine Society's 93rd Annual Meeting in Boston.

"Maintaining adequate vitamin D levels above those recently recommended by the IOM is important for optimizing a standard therapy for osteoporosis: ," said coauthor Richard Bockman, MD, PhD, chief of the endocrine service at Hospital for Special Surgery and professor of medicine at Weill Cornell Medical College, both in New York City.

Last November the Institute of Medicine (IOM) issued its recommendations on vitamin D intake, reporting that most adults up to age 70 need no more than 600 International Units, or IU, a day to maintain . According to the IOM, this intake, along with adequate calcium, is enough to achieve the minimum adequate vitamin D blood level, measured as serum 25-hydroxyvitamin D, which is 20 nanograms per milliliter (ng/mL).

However, in Bockman's study of 160 with osteoporosis, an average 25-hydroxyvitamin D level of 20 to 30 ng/mL was associated with a high likelihood of not responding to at least 18 months of bisphosphonate treatment. Patients took alendronate, risedronate, ibandronate or zolendronate. The rate of women who were "nonresponders" at this serum vitamin D level was 77.8 percent, compared with 42.3 percent when serum vitamin D was in the range of 30 to 40 ng/mL. Only 24.6 percent were "nonresponders" for a level above 40 ng/mL, the authors reported.

Patients with a hydroxyvitamin D level of 33 ng/mL and above had a sevenfold greater likelihood of having a favorable response to bisphosphonate therapy than below that level, they found.

"This value of at least 33 ng/mL is higher than the level considered as "adequate" by the Institute of Medicine report for the general population and most likely requires a vitamin D intake higher than 600 IU for this therapeutic outcome," Bockman said. "In the future, I think we're going to see vitamin D recommendations based on specific conditions."

The researchers categorized patients as nonresponders if they had a new fracture while receiving a bisphosphonate or if their worsened by more than 3 percent as shown on dual-energy x-ray absorptiometry (DEXA) scans obtained 18 to 60 months apart. Also counted as a nonresponder was any woman with a persistently low DEXA T-score worse than -3 (3 standard deviations below normal).

A typical nonresponse rate to bisphosphonate treatment, according to Bockman, is about 30 percent in an osteoporosis specialty clinic, such as the one from which participants in this study were recruited. Doctors do not generally measure a patient's serum level before beginning bisphosphonate treatment, he said.

Provided by The Endocrine Society search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Obesity weighs down on top soda guzzler Mexico

Artemio Martinez balanced his corpulent frame on a stool in a Mexico City street taco stand, downing a sweet soda and eating a final pork-filled corn tortilla.

Health created 46 minutes ago | popularity not rated yet | comments 0

Consumers largely underestimating calorie content of fast food

People eating at fast food restaurants largely underestimate the calorie content of meals, especially large ones, according to a paper published today in BMJ.

Health created 12 hours ago | popularity not rated yet | comments 0

It's not your imagination: Memory gets muddled at menopause

Don't doubt it when a woman harried by hot flashes says she's having a hard time remembering things. A new study published online in Menopause, the journal of The North American Menopause Society (NAMS), helps confirm with o ...

Health created 13 hours ago | popularity not rated yet | comments 0

Farm bill: Senate rejects GMO labeling amendment

The Senate has overwhelmingly rejected an amendment allowing states to require labeling of genetically modified foods.

Health created 14 hours ago | popularity not rated yet | comments 1

McDonald's can't shake criticism about nutrition

(AP)—McDonald's once again faced criticism that it's a purveyor of junk food that markets to children at its annual shareholder meeting Thursday.

Health created 14 hours ago | popularity not rated yet | comments 0


WHO voices deep concern over spread of SARS-like virus

The World Health Organization voiced deep concern Thursday over the SARS-like virus that has killed 22 people in less than a year, saying it might potentially spread more widely between humans.

Study: No higher cancer rate at Conn. Pratt plant

(AP)—Researchers examining the incidence of brain cancer at jet engine manufacturer Pratt & Whitney in Connecticut say they have found no statistically significant elevations in the rate of cancer among workers.

Controlling mood through the motions of mitochondria

(Medical Xpress)—Regulating the distribution of power in neurons is done by a system that makes the national electric grid look simple by comparison. Each neuron has several thousand mitochondria confined ...

Hormone replacement therapy—clarity at last

The British Menopause Society and Women's Health Concern have today released updated guidelines on Hormone Replacement Therapy (HRT) to provide clarity around the role of HRT, the benefits and the risks. The new guidelines ...

Motion quotient: IQ predicted by ability to filter motion (w/ video)

A brief visual task can predict IQ, according to a new study. This surprisingly simple exercise measures the brain's unconscious ability to filter out visual movement. The study shows that individuals whose ...

Multiple research teams unable to confirm high-profile Alzheimer's study

Teams of highly respected Alzheimer's researchers failed to replicate what appeared to be breakthrough results for the treatment of this brain disease when they were published last year in the journal Science.